| Literature DB >> 24409219 |
Clint T Miller1, Steve F Fraser1, Itamar Levinger2, Nora E Straznicky3, John B Dixon4, John Reynolds5, Steve E Selig1.
Abstract
BACKGROUND: Obesity is associated with impairments of physical function, cardiovascular fitness, muscle strength and the capacity to perform activities of daily living. This review examines the specific effects of exercise training in relation to body composition and physical function demonstrated by changes in cardiovascular fitness, and muscle strength when obese adults undergo energy restriction.Entities:
Mesh:
Year: 2013 PMID: 24409219 PMCID: PMC3884087 DOI: 10.1371/journal.pone.0081692
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Method for selecting studies to include in this review.
Checklist for appraising the quality of studies included.
| Condition | (a) | (b) | (c) | (d) |
|
| Correct, blinded randomization method described OR randomized, double-blind method stated AND group similarity documented | Blinding and randomization stated but method not described OR suspect technique (e.g. allocation by drawing from an envelope) | Randomization claimed but not described and investigator not blinded | Randomization not mentioned |
|
| Intention to treat analysis AND full follow-up | Intention to treat analysis AND: 15% loss to follow-up | Analysis by treatment received only OR no mention of withdrawals | Analysis by treatment received AND no mention of withdrawals OR more than 15% withdrawals/loss-to-follow-up/post-randomization exclusions |
|
| Blinding of outcome assessor AND patient and care giver | Blinding of outcome assessor OR (patient AND care-giver) | Blinding not done | |
|
| All patients had standardized assessment | No standardized assessment OR not mentioned |
Changes in absolute and relative cardiovascular fitness following energy restriction and energy restriction with exercise training.
| Reference | Δ Absolute VO2peak (SD) ml.min-1 | Δ Absolute VO2peak Relative to baseline (%) | Δ Relative VO2peak (SD) ml.min-1.kg BM-1 | Δ VO2peak.kg BM relative to baseline (%) | Δ Relative VO2peak (SD) ml.min-1.kg LM-1 | Δ VO2peak.kg LM relative to baseline | p-value between group difference for reported outcome measure | |
| Villareal 2011 | ER: | −26* | −1.4* | 1.4 (1.7)# | 8.0* | 1.4* | 4.6* | (2) p = 0.01 |
| ER+E: | 123* | 7.2* | 2.8 (2.3)# | 16.2* | 3.1* | 10.4* | ||
| Nicklas 2009 | ER: | −71 (255) | −3.8* | 2.0 (2.6)§ | 9.6(11.2) § | 1.5* | 4.2* | ER+VE greater than others; (2) p = 0.03 |
| ER+ME: | −8 (213) | −0.4* | 2.5 (2.6)§ | 12.7(12.7) § | 2.3* | 6.4* | ||
| ER+VE: | 68 (252) | 3.8* | 4.1 (3.7)§ | 24.2(27.6) § | 3.8* | 11.0* | ||
| Toledo 2008 | ER: | −58* | −2.5* | 0.42* | 9.8* | 0.7 (NR) | 1.6(4.0) | (3) Not significant |
| ER+E: | 184* | 7.4* | 2.85* | 17.9* | 4.8 (NR)§ | 10.7(3.9) | ||
| Straznicky 2010 | ER: | −56* | −3.9* | −0.18* | 4.0* | −0.3 (0.22) | −1.1* | (3) p<0.05 |
| ER+E: | 240* | 15.5* | 3.15* | 27.0* | 5.1 (0.25)# | 17.5* | ||
| Amati 2008 | ER: | −52* | −8.7* | 0.08* | 20.4* | 0.1 (NR) | 0.4* | (3) p<0.05 |
| ER+E: | 46* | 1.3* | 1.06* | 31.5* | 1.4 (NR)§ | 4.3* | ||
| Messier 2010 | ER: | −100 (NR)§ | −6.7* | −0.09* | −0.5* | −1.51* | −4.6* | (1) Not significant |
| ER+E: | −100 (NR)§ | −6.7* | 0.04* | 0.3* | −1.9* | −5.6* | ||
| Janssen 1999 | ERm: | 140 (150) | NR | NR | NR | NR | NR | (1) ER+AM >ER+AF p<0.01 |
| ERf: | −200 (100) | NR | NR | NR | NR | NR | ||
| ER+AM: | 470 (131)¥ | 17.0 (5) ¥ | NR | NR | NR | NR | ||
| ER+AF: | 200 (50)¥ | 9 (3) ¥ | NR | NR | NR | NR | ||
| ER+RM: | 180 (110) | NR | NR | NR | NR | NR | ||
| ER+RF: | 110 (150) | NR | NR | NR | NR | NR | ||
| Rice 1999 | ER: | NR | NR | NR | NR | NR | NR | NR |
| ER+AT: | NR | 16.1 (14.7)§ | NR | NR | NR | NR | ||
| ER+RT: | NR | NR | NR | NR | NR | NR | ||
| Janssen 2002 | ER: | NR | NR | NR | NR | NR | NR | NR |
| ER+AT: | NR | 9 (9)§ | NR | NR | NR | NR | ||
| ER+RT: | NR | NR | NR | NR | NR | NR | ||
| Foster-Schubert 2012 | ER: | −1.0 (NR) | 1.6* | 1.9* | 0.02* | 0.04* | (1) p = 0.0001 | |
| ER+AT: | 120 (340) § | 6.5 (NR) § | 4.4* | 5.3* | 3.3* | 6.82* |
ER, energy restriction; ER+E, energy restriction and exercise; ER+ME, energy restriction and moderate intensity exercise; ER+VE, energy restriction and vigorous exercise; ER+AT, energy restriction and aerobic training; ER+RT, energy restriction and resistance training; ER+AM male energy restriction and aerobic exercise training; ER+AF female energy restriction and aerobic exercise training; ERm, male energy restriction; ERf, female energy restriction; ER+RM, male energy restriction and resistance training; ER+RF, female energy restriction and resistance training. *Data estimated by calculating from group means (see Methods for more on this). Reported outcome measures: (1) Absolute VO2; (2) VO2 relative to BM; (3) VO2 relative to LM. NR not reported or not able to be calculated. § denotes within group change (p<0.05). ¥ denotes within group change (p<0.01). ∫ denotes within group change (p = 0.02). # denotes significant within group change (p<0.001).
Characteristics of included studies.
| Reference | Sex (n) | Mean age | Mean BMI | Study Duration | Completed | Primary outcomes | Energy restriction protocol | Exercise protocol | Exercise adherence |
| Villareal 2011 | F (33) M (21) | 70 | 37 | 6 mo. | 87% | Physical performance score | 500–750 kcal.day−1 deficit; 1g protein.kg bw.d−1 | 3×90 min.wk−1 supervised RT+AT | 83 (80-88%) |
| Nicklas 2009 | F (95) | 58 | 33 | 5 mo. | 85% | Abdominal adipose tissue, cardiovascular disease risk factors | 400 kcal.day−1 deficit; |
|
|
| Toledo 2008 | F (10) M (6) | 44 | 34 | 5 mo. | 100% | Mitochondrial capacity | ∼25% energy deficit.day-1 | 3–5×40 min.wk-1 AT; ≥1 session supervised | 1.5 (0.2 days) Supervised; 2.5 (0.4 days) Unsupervised |
| Straznicky 2010 | F (20) M (20) | 55 | 32 | 3 mo. | 92% | Sympathoinhibition, metabolic syndrome components | 600 kcal.day-1 deficit; | 3–4×40 min.wk-1 AT; 1 session supervised | NR |
| Amati 2008 | F (15) M (13) | 67 | 32 | 4 mo. | 100% | Exercise efficiency and economy | a500–1,000 kcal.day-1 deficit; <30% cal from fat | 3–5×45 min.wk-1 AT; 3 sessions supervised; 2 sessions unsupervised | 3.6 (0.2 days) |
| Messier 2010 | F (107) | 58 | 32 | 6 mo. | 78% | Psychosocial factors | 500–800 kcal.day-1 deficit; | 3×(2–4 sets of 6 exercises).wk-1 supervised RT | NR |
| Frimel 2008 | F (18) M (12) | 70 | 37 | 6 mo. | 97% | Fat-free mass | 750 kcal.day-1 deficit; | 3×90 min.wk-1 supervised RT+AT | 100% |
| Daly 2005 | F (13) M (16) | 67 | 32 | 6 mo. | 100% | Bone mineral density, lean mass | ER to induce 0.25kg wt loss.wk-1<30% kcal from fat | 3×(3 sets x 8–10 reps of 9 exercises).wk-1 supervised RT | 88% |
| Wycherley 2010 | F+M (59) | 51 | 35 | 4 mo. | 71% | Body mass, body composition, cardiovascular disease risk factors | 1,400–1,600 kcal.day-1; | 3×(2×8–12 of 8 exercises).wk-1 supervised RT | 93 (±8.5%) |
| Bouchard 2009 | F (23) | 62 | 32 | 3 mo. | 96% | Physical capacity | ER to induce 0.5–1.0kg wt loss.wk-1; | 3×(3 set x 8 reps of 9 exercises). wk-1 supervised RT | NR |
| Janssen 1999 | F (30) M (30) | 41 | 33 | 4 mo. | 100% | Skeletal muscle mass | 1,000 kcal.day-1 deficit; <30% kcal from fat. | AT: 5×34 min.wk-1 supervised; RT: 3×(1 set x 8–12 reps of 8 exercises).wk-1 supervised | AT-M: 89 (74–98%); AT-F: 85 (85–98%); RT-M: 95 (81–100%); RT-F: 94 (85–98%) |
| Janssen 2002 | F (38) | 37 | 33 | 4 mo. | 100% | Metabolic risk factors | 1,000 kcal.day-1 deficit; <30% kcal from fat. | AT: 5×34 min.wk-1 supervised; RT: 3×(1 set x 8–12 reps of 8 exercises).wk-1 supervised | AT: 92 (85–98%); RT: 94 (79–100%) |
| Rice 1999 | M (29) | 44 | 33 | 4 mo. | 88% | Glucose tolerance, insulin action | 1,000 kcal.day-1 deficit; <30% kcal from fat. | AT: 5×37 min.wk-1 supervised; RT: 3×(1 set x 8–12 reps of 8 exercises).wk-1 supervised | AT: 92 (74–99%); RT: 96 (85–100%) |
| Foster-Schubert 2012 | F (204) | 58 | 30.9 | 12 mo. | 91% | Body mass | 1,200–2,000 kcal.day-1; <30% kcal from fat. | AT: 5×45 min.wk-1; ≥ 3 sessions supervised. | 85% |
Macronutrient composition (%carbohydrate/%protein/%fat). bw, body weight; RT, resistance training; AT, aerobic training; F, female; M, male; ME, moderate intensity exercise group; VE, vigorous intensity exercise group; ER, energy restriction; HP, high protein diet; STD, standard diet; Energy restriction relate to energy deficit associated with dietary modification and do not include additional energy expenditure from the addition of exercise.
Appraisal of the quality of studies included.
| Reference | Method of treatment assignment | Control of selection bias after treatment assignment | Blinding | Outcome assessment (if blinding was not possible) |
| Villareal 2011 | b | b | c | a |
| Nicklas 2009 | a | b | c | a |
| Toledo 2008 | b | c | c | a |
| Straznicky 2010 | a | c | c | a |
| Amati 2008 | c | c | c | a |
| Messier 2010 | b | d | c | a |
| Frimel 2008 | b | c | c | a |
| Daly 2005 | b | c | c | a |
| Wycherley 2010 | b | c | c | a |
| Bouchard 2009 | b | c | c | a |
| Janssen 1999 | b | c | c | a |
| Janssen 2002 | b | c | c | a |
| Rice 1999 | b | c | c | a |
| Foster-Schubert 2012 | a | a | c | a |
Changes in weight, body composition, fitness and function for all included studies.
| Reference | Δ Body weight Kg (SD) | Δ Body weight % | Δ Lean mass Kg (SD) | Δ Lean mass % | Δ Fat mass Kg (SD) | Δ Fat mass % | Reported VO2peak | Strength | |
| Foster-Schubert 2012 | ER: | −7.2 (NR)#a | −8.5 | −0.8 (NR) | −1.9# | −6.1 (NR) | −15.6#a | ↔ a | |
| ER+AT | −8.9 (NR)#b | −10.8 | −0.4 (NR) | −1.1 | −8.2 (NR) | −20.8#b | ↑b | ||
| Villareal 2011 | ER: | −9.0 (5.4)# | −8.6 | −3.5 (2.7)#a | −5.7 | −6.0 (3.8)# | −14.0 | ↓ a | ↔ a |
| ER+E: | −7.7 (4.2)# | −7.7 | −1.7 (1.7)#b | −3.0 | −5.6 (3.2)# | −13.4 | ↑b | ↑b | |
| Nicklas 2009 | ER: | −11.8 (4.1)# | −12.9 | −4.1 (1.9)# | −7.7 | −7.4 (2.8)# | −18.6 | ↓a | |
| ER+ME: | −12.2 (4.5)# | −13.5 | −3.4 (2.0)# | −6.5 | −8.2 (3.2)# | −20.9 | ↔ | ||
| ER+VE: | −12.3 (4.9)# | −13.9 | −3.3 (1.7)# | −6.4 | −8.5 (3.8)# | −22.0 | ↑b | ||
| Toledo 2008 | ER: | −10.6 (NR)# | −11.2 | −2.1 (NR)# | −4.0 | −7.5 (NR)# | −19.0 | ↔ | |
| ER+E: | −8.5 (NR)# | −9.0 | −1.3 (NR) | −2.5 | −7.1 (NR)# | −17.7 | ↑ | ||
| Straznicky 2010 | ER: | −7.1 (2.7)# | −7.5 | −1.5 (2.2)# | −2.8 | −5.2 (3.1)# | −14.3 | ↓a | |
| ER+E: | −8.4 (4.5)# | −9.0 | −0.9 (1.8)# | −1.7 | −6.9 (4.0)# | −19.5 | ↑ b | ||
| Amati 2008 | ER: | −7.3 (NR)# | −9.2 | −2.0 (NR)#a | −4.3 | −6.3 (NR)# | −16.4 | ↓a | |
| ER+E: | −8.5 (NR)# | −8.5 | −0.8 (NR)b | −1.5 | −6.8 (NR)# | −18.7 | ↑b | ||
| Messier 2010 | ER: | −5.2 (NR)# | −6.2 | −1.0 (NR)# | −2.2 | −3.9 (NR)# | −10.4 | ↓ | ↔ a |
| ER+E: | −5.8 (NR)# | −6.9 | −0.5 (NR)# | −1.1 | −5.3 (NR)# | −13.4 | ↓ | ↑b | |
| Frimel 2008 | ER: | −10.7 (4.5)# | −10.4 | −3.5 (2.1)#a | −5.9 | −6.8 (3.7)# | −16.1 | ↔ a | |
| ER+E: | −9.7 (4.0)# | −10.0 | −1.8 (1.5)b | −3.1 | −7.7 (2.9)# | −19.5 | ↑b | ||
| Daly 2005 | ER: | −3.0 (1.8)# | −3.5 | −0.4 (1.0)a | −0.03 | −2.0 (2.3)# | −6.5 | ↔ a | |
| ER+E | −2.4 (3.0)# | −2.8 | 0.5 (1.1)b | 1.0 | −2.4 (2.9)# | −7.2 | ↑b | ||
| Wycherley 2010 | ERs: | −8.6 (4.6) §#a | −8.9 | −2.2 (1.9) | −3.8 | −6.5 (3.7) §#a | −16.6 | ↔ a | |
| ERhp: | −9.0 (4.8) | −10.0 | −1.9 (1.5) | −3.7 | −7.1 (4.0) | −20.1 | ↓a | ||
| ERs+E: | −10.5 (5.1) §#b | −8.8 | −2.4 (2.5) | −3.0 | −8.1 (3.8) §#b | −17.8 | ↑b | ||
| ERhp+E: | −13.8 (6.0) | −12.8 | −2.4 (3.1) | −3.7 | −11.4 (3.9) | −26.6 | ↑b | ||
| Bouchard 2009 | ER: | −4.0 (NR)# | −5.1 | −0.7 (NR)# | −1.8 | −3.2 (NR)# | −8.9 | ↓ | |
| ER+E: | −3.6 (NR)# | −4.6 | −0.3 (NR) | −0.7 | −3.2 (NR)# | −9.5 | ↓ | ||
| Janssen 1999 | ERm: | −11.7 (3.5)# | −11.9 | −2.9 (1.9)# | −4.4 | −7.5 (2.8)# | −24.2 | ↔ | |
| ERf: | −10.7 (3.8)# | −11.5 | −1.5 (1.3)# | −3.2 | −8.2 (3.5)# | −19.2 | ↔ | ||
| ER+AM: | −11.4 (3.8)# | −11.2 | −1.6 (1.6) | −2.5 | −9.4 (3.8)# | −27.9 | ↑ | ||
| ER+AF: | −11.5 (3.2)# | −11.7 | −0.5 (1.9) | −1.0 | −10.5 (3.8)# | −22.6 | ↑ | ||
| ER+RM: | −12.7 (3.8)# | −11.6 | −1.8 (2.5) | −2.7 | −10.3 (3.8)# | −27.5 | ↔ | ||
| ER+RF: | −10.0 (2.8)# | −11.5 | −0.2 (1.9) | −0.4 | −8.7 (2.2)# | −22.4 | ↔ | ||
| Janssen 2002 | ER: | −10.0 (3.9)# | −11.0 | SM-1.1 (0.8)# | −4.8 | −7.8 (3.1)# | −18.9 | ↔ | |
| ER+AT: | −11.1 (4.4)# | −11.1 | SM-0.6 (1.1) | −2.5 | −9.9 (4.6)# | −20.9 | ↑ | ||
| ER+RT: | −10.0 (3.0)# | −11.6 | SM-0.4 (1.1) | −1.9 | −8.6 (2.4)# | −22.8 | ↔ | ||
| Rice 1999 | ER: | −12.1 (3.4)# | −12.2 | SM -2.5 (1.0L)#a | −7.2 | −8.5 (2.9L)# | −24.9 | ↔ | |
| ER+AT: | −11.5 (3.9)# | −11.4 | SM +0.3 (1.0L)#b | 0.9 | −9.7 (4.6L)# | −28.1 | ↑ | ||
| ER+RT: | −13.6 (4.1)# | −12.4 | SM +0.2 (2.2L)#b | 0.6 | −10.8 (3.5L)# | −27.3 | ↔ |
ER, energy restriction; ER+E, energy restriction and exercise; ER+ME, energy restriction and moderate intensity exercise; ER+VE, energy restriction and vigorous exercise; ERs, energy restriction standard diet; ERhp, energy restriction high protein diet; ER+AT, energy restriction and aerobic training; ER+RT, energy restriction and resistance training; ER+AM male energy restriction and aerobic exercise training; ER+AF female energy restriction and aerobic exercise training; ERm, male energy restriction; ERf, female energy restriction; ER+RM, male energy restriction and resistance training; ER+RF, female energy restriction and resistance training. # significant within group changes with intervention. Values with different letters (a, b) significant between group changes with intervention. §significant difference between combined diet only interventions and combined exercise and diet interventions.NR not reported or not able to be calculated. ↑significant improvement within group; ↓significant decrease within group; ↔no change within group. SM, skeletal muscle mass. Reported VO2peak shows relative VO2peak. Absolute VO2peak is shown if the study did not report relative VO2peak.
Predicted means, over studies, of percentage changes relative to their baseline values in lean mass (LM), fat mass (FM) and body mass (BM) means.
| Variable | ER (n = 14) | ER+A (n = 8) | ER+R (n = 7) | ER+A+R (n = 2) | F-test p-value |
| LM | −3.61±0.61 a | −2.18±0.66 b | −2.49±0.67 b | −1.15±0.90 b | <0.001 |
| FM | −14.77±1.48 b | −18.28±1.67 a | −17.69±1.72 a | −16.20±2.58 a,b | 0.025 |
| BM | −8.59±0.85 | −9.03±0.91 | −9.13±0.93 | −8.05±1.25 | 0.622 |
ER = Energy Restriction, ER+A = Energy Restriction + Aerobic Training, ER+R = Energy Restriction + Resistance Training, and, ER+A+R = Energy Restriction + a combination of Aerobic and Resistance Training. Plus-minus values are predicted means and their standard errors from the linear mixed model analysis. Within a row, corresponding to a variable, predicted means with lower-case letters in common are not significantly different on the basis of LSDs. n is the number of groups exposed to a certain treatment; excludes 2 studies that reported skeletal mass.